Merit Medical Systems Inc/ US5898891040 /
| 2024-04-17 10:00:00 PM | Chg. -1.2400 | Volume | Bid10:09:45 AM | Ask10:09:45 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 71.5100USD | -1.70% | 287,571 Turnover: 13.53 mill. |
28.7500Bid Size: 100 | 113.7000Ask Size: 100 | 4.14 bill.USD | - | 43.60 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 378.7850 | 382.7280 | 371.6580 | 382.9760 | 383.5230 | ||||||
| Intangible Assets | - | - | - | - | - | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 1,302.7830 | 1,234.6890 | 1,166.0820 | 1,134.8820 | 1,216.7740 | ||||||
| Inventories | 225.6980 | 198.0190 | 221.9220 | 265.9910 | 303.8710 | ||||||
| Accounts Receivable | 155.3650 | 146.6410 | 152.3010 | 164.6770 | 177.8850 | ||||||
| Cash and Cash Equivalents | 44.3200 | 56.9160 | 67.7500 | 58.4080 | 587.0360 | ||||||
| Current Assets | 454.5380 | 429.7070 | 482.2120 | 529.0840 | 1,108.4700 | ||||||
| Total Assets | 1,757.3210 | 1,664.3960 | 1,648.2940 | 1,663.9660 | 2,325.2440 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 54.6230 | 49.8370 | 55.6240 | 68.5040 | 65.9440 | ||||||
| Long-term debt | 431.9840 | 343.7220 | 234.3970 | 186.7590 | 823.0130 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 48 | - | - | - | - | ||||||
| Liabilities | 807.3770 | 705.8210 | 608.4950 | 519.5690 | 1,123.2440 | ||||||
| Share Capital | 587.0170 | 606.2240 | 641.5330 | 675.1740 | 638.1500 | ||||||
| Total Equity | 949.9440 | 958.5750 | 1,039.7990 | 1,144.3970 | 1,202 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 1,757.3210 | 1,664.3960 | 1,648.2940 | 1,663.9660 | 2,325.2440 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 994.8520 | 963.8750 | 1,074.7510 | 1,150.9810 | 1,257.3660 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 15.4340 | -1.5620 | 60.9160 | 87.5630 | 123.9440 | ||||||
| Interest Income | -12.4130 | -9.9940 | -5.2610 | -6.3390 | -15.5110 | ||||||
| Income Before Taxes | 2.1930 | -13.2310 | 53.9170 | 82.6290 | 112.0890 | ||||||
| Income Taxes | -3.2580 | -3.3880 | 5.4630 | 8.1130 | 17.6780 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 5.4510 | -9.8430 | 48.4540 | 74.5160 | 94.4110 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 77.8130 | 165.2700 | 147.2310 | 114.2910 | 145.1510 | ||||||
| Cash Flow from Investing Activities | -134.4810 | -58.6520 | -37.1610 | -57.3970 | -175.3470 | ||||||
| Cash Flow from Financing | 33.5330 | -95.7060 | -98.4350 | -60.2600 | 559.2660 | ||||||
| Decrease / Increase in Cash | -23.0390 | 12.5960 | 10.8340 | -7.1920 | 528.5860 | ||||||
| Employees | 6,355 | - | - | - | - | ||||||
